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ABSTRACT 
Objectives: to investigate the effectiveness and predictability of different treatment 
modalities for gain of keratinized tissue (KT) in fully edentulous jaws prior to dental 
implant placement: apically positioned flap (APF), APF plus xenogeneic collagen matrix 
(XCM), APF plus free gingival graft (FGG). 
Materials & Methods: In fully edentulous patients with insufficient zones of KT at the 
prospective implant positions, four treatment modalities were performed in the lower 
jaw: APF, XCM, FGG and an untreated control group (control). APF and XCM were 
applied in the first molar positions, FGG and control in the canine positions. Assessed 
outcomes up to 3 months post-surgery included: changes in width of KT (over a 3-month 
period), histomorphometric analysis of harvested soft tissues biopsies (at 3 months 
postoperatively) and patient-reported outcomes measures (PROMs). 
Results: For the primary outcome, changes in KT width demonstrated an increase of 
1.93 mm ±1.6 mm (APF), whereas XCM and FGG showed an increase of 4.63 mm ± 1.25 
mm and 3.64 ± 2.01, respectively. Histomorphometric analyses revealed a thickness of 
the epithelium ranging between 375±122 um (APF), 410±116um (XCM), 336±122 um 
(FGG) and 413±109um (Control). All biopsies showed a regular muco-periosteal 
structure with a keratinized epithelium of comparable thickness in all groups.  
Conclusion: All three methods were suitable to increase the width of KT, although APF 
alone rendered roughly 50% less gain compared to XCM and FGG. 
Clinical Relevance: The use of XCM in conjunction with an APF represents a 
valuable treatment option for the gain of keratinized tissue in edentulous sites. 
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INTRODUCTION  
 Controversial results are reported with respect to the question whether or not 
there is a need for keratinized tissue around dental implants [1, 2]. Various studies 
suggested associations between an adequate width of keratinized tissue, higher survival 
rates of dental implants, the health of the peri-implant tissue, and an improved esthetic 
outcome [3-5]. More recent studies demonstrated that implants with a reduced width of 
peri-implant keratinized tissue were more prone to plaque accumulation and bleeding as 
well as soft tissue recessions [6-9]. In a randomized clinical study, free gingival grafts 
(FGGs) significantly increased the width of keratinized mucosa around dental implants. 
Moreover, implant sites augmented with FGGs showed a significantly reduced mucosal 
inflammation and less alveolar bone loss [10]. In order to facilitate patients’ oral hygiene 
and to maintain the keratinized mucosa level, techniques to increase the peri-implant 
keratinized tissue have to be considered. Traditionally, grafting procedures are 
performed using autogenous soft tissue transplants [11-13]. However, surgical 
difficulties, lack of color match, and an increased patient morbidity represent major 
disadvantages when using autogenous transplants [14-18]. In order to overcome these 
issues encountered with autogenous grafting, various techniques and biomaterials of 
allogenic and xenogeneic origin were introduced and evaluated in clinical studies to 
increase the width of keratinized tissue [19-24]. Collagen devices from xenogeneic origin 
have been successfully used in dentistry as barrier membranes [25-27], as socket seal 
[28-30] and to gain keratinized tissue [19, 21-23, 31, 32]. Even though, results from 
clinical trials demonstrated that a collagen matrix (XCM) in combination with an apically 
positioned flap (APF) was effective and predictable for attaining a band of keratinized 
tissue [21, 23, 32, 33], a clinical benefit compared to the APF alone has not been shown 
so far.  
The aim of the present pilot study was, therefore, to evaluate four treatment modalities, 
an apically positioned flap (APF), APF plus XCM, APF plus FGG and an untreated control 
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group, in prospective implant positions and to report histologic outcomes three months 
following the surgical interventions. 
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MATERIALS AND METHODS 
Study design 
The present study was designed as a split-mouth pilot case series to evaluate three 
procedures for gain of keratinized tissue and to histologically describe the tissues three 
months after the surgical interventions. The local ethics committee approved the study 
protocol and procedures (KEK-Nr. 2011-0124/5). Patients meeting the following 
inclusion criteria were consecutively recruited and enrolled at the Clinic of Fixed and 
Removable Prosthodontics and Dental Material Science, University of Zürich, 
Switzerland, between 2011-2012: 
- Signed informed consent 
- The patient (male or female) must be 18 years or older 
- The patient is able to comply with the study-related procedures such as 
exercising good oral hygiene and attending all follow-up procedures 
- The patient is able to fully understand the nature of the proposed surgery and is 
able to provide a signed informed consent. 
- Fully edentulous patients in need of implant therapy in the mandible and ability 
to place dental implants in the two canine and the two first molar positions 
- A reduced width of keratinized tissue (<2mm), measured from the center of the 
four prospective mandibular implant positions (canines and first molars) to the 
buccal mucogingival junction 
- Well-fitted, new maxillary and mandibular prostheses 
- Generally healthy 
- Commitment to maintain good oral hygiene 
- No systemic disease that could affect wound healing and prevent implant 
placement 
Exclusion criteria for all subjects included: 
- Patient is a heavy smoker (> 10 cigarettes per day) 
- Patient is an insulin dependent diabetic 
- General contraindications for dental and/or surgical treatment are present. 
- The patient has a history of malignancy, radiotherapy, or chemotherapy for 
malignancy within the past five. 
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- The patient is pregnant or nursing 
- The patient is taking medications or having treatments, which have an effect on 
mucosal healing in general (e.g. steroids, large doses of anti-inflammatory 
drugs). 
- The patient has a disease, which affects connective tissue metabolism (e.g. 
collagenases). 
- The patient is allergic to collagen. 
- Patients having participated in a clinical trial within the last six months. 
Patients not meeting all inclusion criteria were excluded from the study. Upon 
enrollment, alginate impressions of the mandible were obtained and stents for 
measurements were digitally designed and fabricated with a 3D printer (Figure 1). The 
stent was designed in such a way that it allowed measuring the width of keratinized 
tissue from the center of the prospective implant positions to the buccal mucogingival 
junction. 
Surgical intervention 
At the day of surgery, patients rinsed with 0.2% of chlorhexidine solution and were 
given medication for pain relief (Mefenamic acid, 500mg). Subsequently, photographs of 
the four sites were taken, and the width of keratinized tissue was measured on the 
buccal side of the four prospective implant positions using a caliper and the prepared 
stent. Following local anesthesia, four treatment modalities were then randomly applied 
to the left and right side of the mandible:  
Molar positions: 
-  Apically positioned flap (APF)  
- APF plus collagen matrix (XCM) (MucograftÒ Geistlich Pharma AG, Wolhusen, 
Switzerland)  
Canine positions: 
- APF plus autogenous free gingival graft (FGG) 
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- No surgical intervention (control) 
In group APF (Figure 2), a split-flap was prepared leaving 1mm of keratinized tissue 
(KT) at the coronal border of the APF and sutured apically using non-resorbable sutures 
(Dafilons 5-0, B. Braun Melsungen AG, Melsungen, Germany). The periosteum was 
exposed with a height of 7mm and a width of 10mm and left for spontaneous healing. 
At XCM sites (Figure 2), the same procedure (split-flap with 1mm of KT) was performed. 
Subsequently, the XCM was shaped to a final dimension of 5x10mm and sutured 
coronally. A gap of 2mm was left for spontaneous healing between the apical border of 
the XCM and the coronal border of the split-flap. One or two cross-section sutures were 
placed on top of the XCM to stabilize the matrix on the wound bed. In the FGG group 
(Figure 2), a similar APF was performed (including 1mm of KT). A FGG with a thickness 
of 1.5mm and a dimension of 5x10mm was harvested from the palate. The FGG was 
sutured coronally and stabilized with one or two cross-section sutures. Similar to XCM 
sites, 2mm of periosteum were left for healing by secondary intention. One site was left 
as a negative control group (no further intervention) (Figure 2).  
Patients were given medications for pain relief (Mefenamic acid, 500mg every 8 hours), 
as well as a disinfectant solution (Chlorhexidine digluconate, 0.2% solution for rinsing 
every 8 hours for a period of 7 days). No adaptations were made to the mandibular 
prostheses and patients were allowed to wear them during the entire study period. At 
day 7 post-surgery, all patients were recalled for suture removal, clinical measurements 
and clinical photographs. 
Outcome measures 
Width of keratinized tissue 
The width of keratinized tissue at the four sites was recorded to the nearest 0.1mm at 
baseline (prior to surgery), after surgery, at 7 days, 30 days, and at 90 days using a 
caliper and 3D-printed stent (Bio-compatible PolyJet photopolymer (MED610), 
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Stratasys, MN, USA) to standardize the measurements for reference and accurate 
reproducibility (Figure 1). The measurements were performed 5 times at a 1mm 
distance and per site. One examiner not involved in the clinical procedure performed all 
the measurements. Intra-examiner reproducibility was assured by pre-operative 
calibration and training program on 3D-printed stent insertion, stabilization and 
consistent data collection.  
  
Patient-reported outcome measures 
Patient-reported outcome measures (PROMs) were evaluated post-surgically. For that 
purpose, a questionnaire was handed out and explained to the patients. Assessed 
parameters included bleeding, swelling and pain. Patients recorded their binary answers 
(yes/no) for bleeding (immediately post-surgery and on the following day) and for 
swelling (post-surgery to 7 days). Patients’ pain experience was evaluated using a visual 
analogue scale (VAS) ranging from 0-10, with 0 representing the absence of pain, 1-3 
for minimal pain, 4-6 for moderate and 7-10 for severe pain. 
 
Histologic processing and analysis 
At 90 days following soft tissue augmentation, clinical measurements and photographs 
were obtained (Figure 2). In the four prospective implant positions, soft tissue biopsies 
were obtained using a biopsy drill (diameter 1.8mm; depth 5mm). Specimens were 
placed in 10% neutral-buffered formalin solution for fixation. Subsequently, implant 
placement was performed according to the manufacturer’s recommendation (data not 
reported here). After fixation, each sample was processed and dehydrated in alcohol 
solutions of increasing concentration, cleared in isoparaffin H and embedded in paraffin. 
Embedded samples were cut at 5 µm using a microtome (MICROM®, France), sections 
were prepared and stained with H&E.   
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All histological sections were evaluated using a Nikon microscope (ECLIPSE E600, Nikon, 
Egg, Switzerland) for qualitative and semi-quantitative histological analysis. For 
histomorphometric analysis, the digitized histological images were analyzed using an 
image-processing program (Image J, NIH, Bethesda, USA), to assess the thickness of 
keratinized epithelium (Figure 3). 
Statistical analysis  
Statistical analyses were performed descriptively to compare the different treatment 
modalities at 30 and 90 days and for changes over time. Current statistics (mean, 
standard deviation, median and IQR) were used to describe the quantitative parameters 
of keratinized tissue width and microscopic thickness of the epithelium (day 90). Due to 
the small sample size, no further statistical tests were performed. 
Results   
A total of 9 patients (36 sites) in fully edentulous patients with an age range between 
46-88 years (mean 66.3 years) were included in the study and underwent soft tissue 
augmentation surgeries. All patients received 4 treatment modalities, healing was 
generally uneventful and no local infection was observed at suture removal. Patient-
related outcomes at day 7 postoperatively were collected in form of a questionnaire. In 
33% of the sites (irrespective of the treatment modality), moderate to severe pain was 
reported. Absence of pain was reported in 13.9 % of the sites only (Table 1).  
Width of keratinized tissue 
All data are presented in Table 2. Immediately post surgery, the gain in KT obtained due 
to the surgical interventions ranged between 3.69mm ± 1.62mm (APF), 4.31mm ± 
0.76mm (XCM), 4.44mm ± 1.44mm (FGG) and 0.0mm ± 0.0mm (control). 
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Between preoperative and 90 days, the gain in width of KT up to 90 days was 1.93 mm 
±1.6 mm for APF, 4.63 mm ± 1.25 mm for XCM, 3.64 ± 2.01 mm for FGG and 0.13mm ± 
0.31mm for control.  
From postoperative to day 90, the width of KT decreased by 35.5 % for APF, increased 
by 6.8 % for XCM, and decreased by 16.8% for FGG and increased by 3.4 % for control 
sites. 
Descriptive histology 
Eight out of 9 patients agreed to take biopsies at 90 days post surgery. In all 8 patients, 
4 biopsies were collected at the prospective implant positions. A total of 24 biopsies 
could be processed and analyzed. This included 5 APF, 5 XCM sites, 7 FGG sites and 7 
control sites. Microscopically, the harvested soft tissues appeared to be healthy. In the 
most coronal part of the biopsy, the oral epithelium had a regular appearance with all 
four components, a keratinized stratum corneum with a keratin layer, a stratum 
granulosum, a stratum spinosum and a stratum basale. Rete pegs were present, but 
had an irregular appearance in most cases. The subepithelial connective tissue appeared 
to have a loose structure with relatively thin bundles of collagen fibers in most biopsies, 
whereas in some samples, thick bundles of collagen fibers were surrounded by an 
increased number of blood vessels. Few inflammatory cells (macrophages, lymphocytes, 
granulocytes) were present in the most coronal portion of the connective tissue 
compartment. In APF and XCM sites, the structure and shape of the epithelium 
underlying connective tissue appeared to be quite consistent, while in control and FGG 
sites, more inconsistencies and irregularities of shape and form were visible. Some 
remnants of the collagen matrices were observed in XCM sites in the most coronal part 
of the connective tissue. 
Histomorphometric outcomes 
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The histomorphometric analysis revealed a thickness of the epithelium ranging between 
375±122 um (APF), 410±116um (XCM), 336±122 um (FGG) and 413±109um (control) 
at 90 days post surgery (Figure 4A-D). 
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Discussion  
The present study evaluating three methods to increase the width of keratinized tissue 
in fully edentulous mandibles revealed that: i) in posterior sites, XCM was more 
effective in terms of gain of KT than APF alone, ii) in anterior sites, FGG resulted in a 
gain similar to XCM sites in the posterior region, iii) postoperative bleeding occurred 
frequently and irrespective of the treatment modality, iv) absence of pain was more 
frequently observed for APF and XCM sites than for FGG sites, v) similar histologic 
outcomes in all groups at 90 days post-surgery. 
To date, there is no data available assessing the use of collagen matrix in fully 
edentulous jaws prior to implant placement, aiming at gain of keratinized tissue. 
Moreover, the clinical and patient benefit of an XCM compared to an apically positioned 
flap alone is unknown. The APF procedure, without incorporating any additional grafting 
material (XCM, FGG) covering the wound bed, resulted in the least gain of keratinized 
tissue. Few studies showed similar outcomes when using an APF to regenerate KT in 
partially edentulous patients [34, 35]. In a case report of 3 patients, an average of 1.5 
mm of KT was gained 3-4 weeks post-APF procedure [35]. Another clinical study 
showed an increase of 2 mm, after 3 months of APF procedure, that decreased to 1.15 
mm at the 12-month follow up [34]. Bearing in mind that a minimum of 2 mm width of 
KT is generally considered to be sufficient and that it is however unknown if a wider 
band of KT is clinically more advantageous [8, 9, 36], the obtained gain through an APF 
might still have its clinical indication.  
Collagen matrices were applied for various clinical indications, including gingival 
recession coverage and to increase the width and thickness of gingival/ peri-implant 
keratinized mucosa [12, 19-22, 37]. The present XCM has a 3-dimensional structure to 
support the tissue growth, while allowing the cellular adhesion and infiltration into its 
interconnected porosity [38]. It is made of a collagenous framework that is 
biocompatible and biodegradable to be replaced by native tissue [20, 38-40]. The 
  13 
present clinical findings demonstrated an increase in KT width by more than double 
compared to APF alone. It might in part be explained by the previously mentioned 
favorable biologic and chemical properties.  
Traditionally, autogenous free gingival grafts were considered to be the gold standard 
for its high success and predictability, as well as the lack for comparable alternatives 
[11, 12, 41-43]. In the present study, XCM regenerated a width of keratinized tissue 
that was comparable to the FGG sites at 3 months. These findings are in line with 
previous clinical studies [19-21, 23, 32, 43]. Since the sites (FGG at canine positions; 
XCM at molar positions) were not randomized and differed between the area/treatment 
modalities and based on the pilot character of the study, the results were only 
compared descriptively without applying further statistical tests. This pilot study could 
however be of value for the power calculation and design of future studies. 
It is accepted to expect some degree of wound contraction and augmentation shrinkage 
irrespective of the procedure and materials used. Postsurgical soft tissue changes in 
width and overall shrinkage are a valuable indicative of technique predictability. 
Literature has shown a wide variation in the amount of shrinkage associated with similar 
or different augmentation procedures [12]. The present findings showed shrinkage rates 
of 35.5% for APF and of 16.8 % for FGG sites, 3 months postoperatively. In contrast, 
XCM sites revealed an increase of 7% relative to the postoperative width of KT. 
Variations in soft tissue changes could be influenced by a number of factors: the 
surgical technique (APF vs. APF/FGG vs. APF/XCM), the augmentation site (anterior vs. 
posterior, periodontal vs. peri-implant), type (XCM, FGG), the characteristics of the 
grafting material (thickness and prevascularity) and the amount of bone atrophy in the 
surgical area that could sustain unfavorable muscle attachment [44]. APF, XCM and FGG 
were reported to exhibit the majority of shrinkage within the first 3 months post surgery 
[23, 33, 34, 43]. Published data indicated, for XCM and FFG, a maximal shrinkage of 
67% and 60%, respectively, one month postoperatively [23], a shrinkage of 20% at 2 
months (XCM) [33] and a shrinkage of 34% (XCM) and 28.6% (FGG) at 3 months [21]. 
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All these shrinkage rates are higher than the ones observed in the present study. One 
possible explanation includes that all patients were fully edentulous and wearing their 
prostheses as opposed to the above-mentioned studies including tooth and implant sites 
in partially edentulous patients. The prostheses in the present study might have served 
as an artificial wound dressing by keeping a continuous pressure on the wound bed and 
by stabilization the augmented area. Another important factor is that most of clinical 
studies, including ours, presented relatively short-term findings. Although long-term 
studies are limited, a 5-year clinical study showed continuous but minimal rates of 
dimensional changes after the first 3 months of the treatment. The XCM-treated sites 
showed more significant reduction in KT compared to FGG at 3-, 4- and 5-year follow up 
visits. Yet, KT maintained an adequate and supportive peri-implant keratinized tissue in 
both groups [21].  
Histologically, the biopsies showed a similar keratinization of multilayer epithelial cells, 
as well as a normal maturation of connective tissue structures. These histologic findings 
have been consistently described in previous studies assessing biopsies taken following 
augmentation with XCM and FGG [19, 20, 43]. The histomorphometric analysis also 
revealed XCM-site biopsies to have a slightly thicker epithelial layer (410±116 um) 
compared to sites with FGG (336±122 um) and APF alone (375±122 um). Moreover, 
the data were comparable to sites without surgical intervention (control sites: 413±109 
um). These findings demonstrate that within a 3-month period, irrespective of the 
treatment modality, stable soft tissue conditions can be expected. This is in line with 
observations from previous in vivo studies comparing collagen matrices and sites 
healing spontaneously that demonstrated no differences at the respective study 
endpoints between 1 and 6 months [45, 46].  
Patients’ perception on dental care is becoming a vital tool and central outcome in 
clinical studies. In the present study, each patient received 3 surgical interventions 
within one appointment. Despite the augmented effect of different within-patient 
interventions, bleeding, swelling and pain were within ’well-tolerated’ range. In general, 
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patients had the perception of ’’mild-moderate’’ within the first week postoperatively. 
Moreover, patients reported absence of pain more frequently with APF and XCM 
compared to FGG. Postoperative bleeding and swelling occurred frequently, and 
irrespective of the treatment modality. These data are further limited and need to be 
interpreted with caution due to the lack of an overall randomization and a relatively low 
number of patients. It is also more indicative for future studies to investigate and 
compare similar anatomical sites for the intervention of interest, over a longer period of 
follow up.  
CONCLUSIONS 
All three methods were suitable to increase the width of KT, although APF alone 
rendered roughly 50% less gain compared to XCM and FGG. From a histologic point of 
view, all three-treatment modalities led to matured and stable soft tissues similar to 
native gingival tissue three months following the surgical interventions.  
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FIGURE LEGENDS 
Figure 1  
3D printed surgical stent for reproducible clinical measurements, inserted on an 
edentulous mandible. Treatment modalities: lower left: FGG; lower right: control; upper 
left: APF; upper right: XCM. APF = apically positioned flap; XCM = xenogeneic collagen 
matrix; FGG = free gingival graft. 
 
Figure 2 
Clinical situation at 90 days. Treatment modalities: lower left: FGG; lower right: control; 
upper left: XCM; upper right: APF. APF = apically positioned flap; XCM = xenogeneic 
collagen matrix; FGG = free gingival graft.  
 
Figure 3 
Histologic section (H&E staining), showing the epithelial measurements (magnification 50 
X). 
 
Figure 4  
A-D: Histologic sections (H&E staining) 90 days after surgery (original magnification 
x50). A: apically positioned flap (APF) site. B: XCM (xenogeneic collagen matrix) site. C: 
FGG (free gingival graft) site. D: control site. 
 
Table 1 
7-day postoperative patient-related outcome measures. APF = apically positioned flap; 
XCM = xenogeneic collagen matrix; FGG = free gingival graft. 
 
Table 2  
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Width of keratinized tissue (Δ mean mm, standard deviation (SD), median, quartile 1 
and quartile 3). APF = apically positioned flap; XCM = xenogeneic collagen matrix; FGG 
= free gingival graft; SD = standard deviation; Q1 = quartile 1; Q3 = quartile 3. 
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Table 1 
Bleeding 
immediately 
post-surgery 
Bleeding 
1-day post-
surgery 
Swelling Pain 
Absent 
0 
Pain 
Minimal 
1-3 
Pain 
Moderate 
4-6 
Pain 
 Severe 
7-10 
APF 3 (37%) 1 (12.5%) 3 (37%) 2 (25%) 3 (37%) 3 (37%) 0 
XCM 3 (37%) 1 (12.5%) 5 (62.5%) 2 (25%) 3 (37%) 2 (25%) 1 (12.5%) 
FGG 4 (50%) 2 (25%) 5 (62.5%) 1 (12.5%) 4 (50%) 3 (37%) 0 
Table 2 
Treatment 
modality 
Observation 
period  
Change in width of keratinized 
tissue (mm) 
Δ Mean SD Median Q1 Q3 
APF Pre- to Postoperative 3.69 1.62 4 3.4 5 
XCM Pre- to Postoperative 4.31 0.76 4.6 3.8 5 
FGG Pre- to Postoperative 4.44 1.44 4.85 4.15 5.2 
 Control Pre- to Postoperative 0 0 0 0 0 
APF 
Preoperative to 30 
days 
3.1 1.71 2.7 1.75 3.95 
XCM 
Preoperative to 30 
days 
4.35 1.81 3.9 3.1 4.75 
FGG 
Preoperative to 30 
days 
4.071 1.43 4.8 3.1 5.15 
Control 
Preoperative to 30 
days 
0.16 0.29 0 0 0 
APF 
Preoperative to 90 
days  
1.93 1.6 1.7 0.7 2.3 
XCM 
Preoperative to 90 
days 
4.63 1.25 4.5 3.6 6 
FGG 
Preoperative to 90 
days 
3.64 2.01 4.3 2.1 4.7 
Control 
Preoperative to 90 
days 
0.13 0.312 0 0 0 
